Category: BioTech

Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

Credit Suisse Reports a Strong First Quarter

Credit Suisse CS earned CHF 1,026 million (CHF 0.76 per diluted share) in the first quarter compared with CHF 41 million in the year-ago quarter and CHF 221 million in the trailing quarter on better trading results and lower expenses. This quarter’s reported profit, which included CHF 80 million of noncash own-debt losses, amounted to an 11% return on equity. On a management-provided underlying basis, … Continue reading Credit Suisse Reports a Strong First Quarter

John MeadyLeave a comment
PRAN NASDAQ PRAN Prana Biotechnology
BioTech, Finance

Biotech Stocks to Watch Veracyte Inc. (NASDAQ VCYT) & RXi Corp (NASDAQ RXII)

Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Veracyte Inc. (NASDAQ VCYT) & RXi Corp (NASDAQ RXII). Both had some major announcements to be made in the past month and the stocks have since shown some very positive upside. Veracyte Inc (NASDAQ VCYT) a molecular diagnostics company pioneering the field of molecular cytology, on 3 July announced that … Continue reading Biotech Stocks to Watch Veracyte Inc. (NASDAQ VCYT) & RXi Corp (NASDAQ RXII)

Richard Atkins
Biotech stock market news
BioTech, Finance

Biotech Stocks : Top Stocks Celldex Therapeutics Inc (NASDAQ CLDX) & Dyax Corp. (NASDAQ DYAX)

Here in this article, we take a look at two very promising Biotech stock: Celldex Therapeutics Inc (NASDAQ CLDX) & Dyax Corp (NASDAQ DYAX). Dyax Corp (NASDAQ DYAX) has had the stock price surge after the company made some major announcements in the past couple of months. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is hoping for similar fortunes, with the stock targeting a positive upside in the … Continue reading Biotech Stocks : Top Stocks Celldex Therapeutics Inc (NASDAQ CLDX) & Dyax Corp. (NASDAQ DYAX)

Richard Atkins
BioTech, Finance, Internet

Google Inc (NASDAQ GOOG) partners with Novartis to develop New Contact Lens

Google Inc (NASDAQ GOOG) and Swiss drugmaker Novartis AG (ADR) have announced an amazing development, one sure to be a significant point of differentiation in Google’s plans to beat Apple Inc (NASDAQ AAPL) and Samsung Electronics Co. Ltd in the race to control consumers healthcare applications.. The product under joint development is “smart” contact lenses. According to the developers, new contact lenses would monitor Glucose … Continue reading Google Inc (NASDAQ GOOG) partners with Novartis to develop New Contact Lens

Richard Atkins
Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

Kirby’s Coastal Operations Continue to Improve in the First Quarter

Kirby’s KEX first-quarter revenue fell 1% from last year. The decline was driven by anemic demand for United’s pressure pumping units, tempered by solid inland trends and improvement in coastal operations. The marine transportation business (75% of first-quarter sales) saw revenue increase 25%, thanks to persistent petrochemical and crude oil shipment demand, which is supporting 90%- plus inland-fleet utilization and favorable pricing. Market conditions in … Continue reading Kirby’s Coastal Operations Continue to Improve in the First Quarter

John MeadyLeave a comment
BioTech, Finance

Active Biotech Stocks Vertex Pharmaceuticals & Ligand Pharmaceuticals

In this article, we take a look at two stocks which have been in news recently, Vertex Pharmaceuticals & Ligand Pharmaceuticals. Keep an eye out for Vertex Pharmaceuticals (NASDAQ VRTX) and Ligand Pharmaceuticals (NASDAQ LGND) . Vertex has performed really well in the recent weeks, recording almost a 50% rise in its price levels. Ligand has also had some very positive developments revolving around new … Continue reading Active Biotech Stocks Vertex Pharmaceuticals & Ligand Pharmaceuticals

Richard Atkins